GLP1R and diabetes mellitus: In contrast, the finding that GLP-1R deletion in β cells (42) or the use of Ex9, an antagonist of the GLP-1R (44), leads to enhanced susceptibility to STZ-induced apoptosis, demonstrates that GLP-1 receptor signaling is an important physiological determinant of β cell survival in a preclinical model of diabetes.